Search - tctmd.com

Displaying 1 - 20 of 81

Sort: Relevancy | Date

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

News Conference News ESC 2025

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

Michael O'Riordan

September 01, 2025

News Conference News ESC 2025

Vericiguat Misses Mark in Stable, Well-Treated HFrEF Patients: VICTOR

Michael O'Riordan

August 31, 2025

News Conference News ESC 2025

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Michael O'Riordan

August 29, 2025

News Daily News

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

Yael L. Maxwell

August 18, 2025

News Conference News NY Valves 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Yael L. Maxwell

July 03, 2025

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Todd Neale

February 19, 2025

News Daily News

Is It Time for an ‘Interventional Heart Failure’ Subspecialty?

Yael L. Maxwell

February 19, 2025

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Todd Neale

February 12, 2025

News Daily News

Just One in Five Grand Rounds Lectures Given by Women

Michael O'Riordan

January 07, 2025

News Daily News

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

Yael L. Maxwell

December 17, 2024

News Daily News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

L.A. McKeown

December 13, 2024

News Conference News AHA 2024

Nasal Bumetanide Safe, Effective in Healthy Adults

Yael L. Maxwell

November 18, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

Internists in HF: A Solution to a Lack of Care?

Yael L. Maxwell

March 19, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

Protein Risk Score Predicts Mortality in Real-world HF Patients

Caitlin E. Cox

January 04, 2024

Advertisement

What’s Going to Be Hot at AHA 2025?

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

Vericiguat Misses Mark in Stable, Well-Treated HFrEF Patients: VICTOR

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Is It Time for an ‘Interventional Heart Failure’ Subspecialty?

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Just One in Five Grand Rounds Lectures Given by Women

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

Nasal Bumetanide Safe, Effective in Healthy Adults

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Internists in HF: A Solution to a Lack of Care?

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Protein Risk Score Predicts Mortality in Real-world HF Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content